About Gateway Pharmacology
Gateway Pharmacology is a Healthcare company based in Chesterfield (United States) founded in 2012, and was acquired by Inotiv in August 2021. Preclinical CRO offering rodent models for evaluating safety and efficacy of drugs, mainly in 6 major disease areas. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include PsychoGenics, InVivo Biosystems and Noble Life Sciences; 2 of its 3 listed competitors have raised funding.
Company details
Gateway Pharmacology was founded in 2012 in Chesterfield, United States, as a preclinical contract research organization. Services are delivered in three categories: disease pharmacology targeting hypertension, nephropathy, heart failure, fibrosis, metabolic diseases, and gastrointestinal disorders; safety pharmacology covering cardiac testing, renal function, and chronic infusions; and infusion pharmacology including PKPD studies, renal clearance, and biliary excretion. Operations occur in an AAALAC-accredited vivarium.
- Headquarters Chesterfield, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gatewaypharmacology.com
- Social LinkedIn
- Acquired by Inotiv (Aug 2021)
Investors in Gateway Pharmacology
Gateway Pharmacology has secured backing from 1 investor. Prominent investors backing the company include Inotiv Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical development and regulatory services are provided by Inotiv. | 1974 | inotivco.com | Lafayette, United States |
Investor details for Gateway Pharmacology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Gateway Pharmacology
2 dated milestones of Gateway Pharmacology across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Gateway Pharmacology is founded.
- Exit Acquired by Inotiv.
Competitors of Gateway Pharmacology
Gateway Pharmacology has 3 listed competitors in our database, 2 of them funded. They include PsychoGenics, InVivo Biosystems and Noble Life Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| psychogenics.com | 1999 | Tarrytown, United States | 124 | Preclinical CRO services for CNS and orphan disorders are offered. | ||
| invivobiosystems.com | 2019 | United States | $8.16M | Animal models are supplied for in-vivo analytical services. | ||
| noblelifesci.com | 2010 | Woodbine, United States | $335,000 | Preclinical contract research organization offering standard GLP and non-GLP services |
Detailed competitors of Gateway Pharmacology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Gateway Pharmacology (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gateway Pharmacology
Complete news archive for Gateway Pharmacology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gateway Pharmacology
Gateway Pharmacology was founded in 2012.
Gateway Pharmacology is headquartered in Chesterfield, United States. It is registered at Chesterfield, Missouri, United States.
Gateway Pharmacology was founded in 2012 in Chesterfield, United States, as a preclinical contract research organization. Services are delivered in three categories: disease pharmacology targeting hypertension, nephropathy, heart failure, fibrosis, metabolic diseases, and gastrointestinal disorders; safety pharmacology covering cardiac testing, renal function, and chronic infusions; and infusion pharmacology including PKPD studies, renal clearance, and biliary excretion. Operations occur in an AAALAC-accredited vivarium.
Gateway Pharmacology's top competitors include PsychoGenics, InVivo Biosystems and Noble Life Sciences.
Gateway Pharmacology has 1 investor. Key investors include Inotiv Co.
Yes. Gateway Pharmacology was acquired by Inotiv in August 2021.